Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women

  • E. Ghigo
  • , G. Aimaretti
  • , M. Maccario
  • , G. Fanciulli
  • , E. Arvat
  • , F. Minuto
  • , G. Giordano
  • , G. Delitala
  • , F. Camanni

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

The aim of our study was to define the dose-response effect of a short- term treatment with different recombinant human growth hormone (rhGH) doses (1.25, 2.5, 5.0, 10.0, and 20.0 μg · kg-1 day-1 for 4 days) on insulin- like growth factor I (IGF-I) and insulin-like growth factor-binding protein (IGFBP)-3 levels in 21 normal young adults of both sexes. The dose of 1.25 μg/kg rhGH did not modify IGF-I levels. The dose of 2.5 μg/kg rhGH significantly increased IGF-I levels in men (P < 0.05) but not in women, whereas the higher doses increased IGF-I levels in both sexes (P < 0.002). IGFBP-3 levels were not modified by 1.25 or 2.5 μg/kg rhGH in either sex. On the other hand, 5.0 μg/kg increased IGFBP-3 levels in men (P < 0.05) but not in women, whereas the higher doses increased IGFBP-3 levels similarly in both sexes (P < 0.02). In conclusion, our results demonstrate that IGF-I and IGFBP-3 responses to rhGH are dose and sex dependent. However, IGFBP-3 is less sensitive than IGF-I to rhGH stimulation.

Lingua originaleInglese
pagine (da-a)E1009-E1013
RivistaAmerican Journal of Physiology - Endocrinology and Metabolism
Volume276
Numero di pubblicazione6 39-6
DOI
Stato di pubblicazionePubblicato - giu 1999
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women'. Insieme formano una fingerprint unica.

Cita questo